Navigation Links
Testosterone levels could serve as a marker for determining risk of SIDS

A recent study conducted on the Sudden Infant Death Syndrome (SIDS) has found out that nearly all cases are associated with an increase in testosterone levels. Testosterone is a male sex hormone. //The levels are considerably higher in infants who have died suddenly from SIDS than in infants who have died suddenly from other causes.

Researchers from the University of Washington compared hormone levels in blood collected from 169 infants who had died of SIDS and 42 who died of other causes. A significant elevation of the male hormone levels were found in the cases studied. In contrast, levels of estradiol, an estrogen-type hormone, did not differ significantly between SIDS victims and the control group.

SIDS is the sudden and unexplained death of an infant. It is the leading cause of death among infants who are 1 month to 1 year old. SIDS should be diagnosed only when all other possible causes of death have been ruled out by a detailed evaluation of the medical history. There is no specific symptom to diagnose the condition

Previous studies have already hinted the possibility of a link between SIDS and sex hormone levels, such as the correlation between the rise in sex hormone levels and the age range of risk for SIDS. Moreover, testosterone levels have also been implicated in a number of sleep disorders associated with breathing difficulties in adults. Any alteration in the levels of the sex hormones (testosterone and estrogen) can affect the nerve structure and function in older and younger male and female animals. More importantly, any increase in these levels following birth can result in a compromise involving the nervous system in otherwise-normal infants.

In conclusion, further research is needed to determine whether testosterone is abnormal in living infants at risk for SIDS and to determine the value of monitoring testosterone or related hormones to identify those infants at increased risk of SIDS.
'"/>




Page: 1

Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone patch for women Rejected For safety Reasons
6. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
7. Testosterone Therapy can improve sexual function in postmenopausal women
8. Fatherhood Found To Tame Men by Reducing Testosterone Levels
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/21/2017)... , ... September 21, 2017 , ... ... their communities, nine governmental public health departments have been awarded five-year accreditation status ... mean that the benefits of being served by a PHAB-accredited health department ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... The New ... with autism, announced today the election of Yie-Hsin Hung to the Board of Directors. ... join our Board of Directors. Ms. Hung is an invaluable addition to our team,” ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand that specializes ... to the athletic wear market with the launch of their FlipBelt Crops. , The ... essentials securely at their fingertips while at the gym, on the trail, or on-the-go. ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Prescott, Arizona, is now accredited by The Joint Commission for chemical dependency and ... accredits and certifies U.S. health care organizations that meet the commission’s rigorous standards. ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... voice for people who have kidney disease. The theme “Describe a positive decision ... stories. Entrants needed to meet only one qualification— to have been diagnosed ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and Company ... and secondary endpoint data for lasmiditan, an investigational, oral, ... demonstrated statistically significant improvements compared to placebo in the ... today at the 18th Congress of the International Headache ... "The data presented today demonstrate lasmiditan,s potential to ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology: